<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9607835</journal-id>
<journal-id journal-id-type="pubmed-jr-id">20545</journal-id>
<journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Molecular psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">1359-4184</issn>
<issn pub-type="epub">1476-5578</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28809400</article-id>
<article-id pub-id-type="pmc">6432924</article-id>
<article-id pub-id-type="doi">10.1038/mp.2017.164</article-id>
<article-id pub-id-type="manuscript">NIHMS1010278</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Alachkar</surname>
<given-names>A</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yoshimura</surname>
<given-names>R</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hamzeh</surname>
<given-names>AR</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanathara</surname>
<given-names>N</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lee</surname>
<given-names>SM</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abbott</surname>
<given-names>GW</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Civelli</surname>
<given-names>O</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Pharmacology, School of Medicine, University of California, Irvine, Irvine, CA, USA</aff>
<aff id="A2"><label>2</label>Centre for Arab Genomic Studies, Dubai, United Arab Emirates</aff>
<aff id="A3"><label>3</label>Department of Anatomy &amp; Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA, USA</aff>
<aff id="A4"><label>4</label>Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, CA, USA</aff>
<aff id="A5"><label>5</label>Department of Pharmaceutical Sciences, School of Medicine, University of California, Irvine, Irvine, CA, USA</aff>
<aff id="A6"><label>6</label>Department of Developmental and Cell Biology, School of Medicine, University of California, Irvine, Irvine, CA, USA.</aff>
<aff id="A7"><label>7</label>These authors contributed equally to this work.</aff>
<author-notes>
<corresp id="CR1">Correspondence: Dr A Alachkar, Department of Pharmacology, School of Medicine, University of California, Irvine, 355 Med Surge II Irvine, CA 92697-4625, USA. <email>aalachka@uci.edu</email></corresp>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">AA and OC conceived the project and wrote the manuscript. AA, OC and LW designed the experiments. AA, LW, RY, SML and ZW conducted the experiments, ARH carried out the genetic analyses, XX and GWA supervised the transcriptomic and electrophysiological studies and helped with the preparation of the manuscript.</p>
</fn>
<fn fn-type="COI-statement" id="FN2">
<p id="P64">CONFLICT OF INTEREST</p>
<p id="P65">The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>1</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>15</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>25</day>
<month>3</month>
<year>2019</year>
</pub-date>
<volume>23</volume>
<issue>2</issue>
<fpage>282</fpage>
<lpage>294</lpage>
<!--elocation-id from pubmed: 10.1038/mp.2017.164-->
<abstract id="ABS1">
<p id="P3">The methionine-folate cycle-dependent one-carbon metabolism is implicated in the pathophysiology of schizophrenia. Since schizophrenia is a developmental disorder, we examined the effects that perturbation of the one-carbon metabolism during gestation has on mice progeny. Pregnant mice were administered methionine equivalent to double their daily intake during the last week of gestation. Their progeny (MET mice) exhibited schizophrenia-like social deficits, cognitive impairments and elevated stereotypy, decreased neurogenesis and synaptic plasticity, and abnormally reduced local excitatory synaptic connections in CA1 neurons. Neural transcript expression of only one gene, encoding the Npas4 transcription factor, was &gt;twofold altered (downregulated) in MET mice; strikingly, similar <italic>Npas4</italic> downregulation occurred in the prefrontal cortex of human patients with schizophrenia. Finally, therapeutic actions of typical (haloperidol) and atypical (clozapine) antipsychotics in MET mice mimicked effects in human schizophrenia patients. Our data support the validity of MET mice as a model for schizophrenia, and uncover methionine metabolism as a potential preventive and/or therapeutic target.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>